Postpartum New Parent
AI recommendation signal analysis across 395 domains for the Postpartum New Parent persona in Behavioral Health Therapy Platforms.
This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.
Get in touch →How to use this page
Crack the listicles
The "top and best" roundups that define this market for searchers and LLMs alike. These lists feed AI recommendations directly, so getting added to them is one of the highest-leverage moves in this report.
Where the numbers come from
We run top, best companies queries for this industry through Google and aggregate every result: domains by rank-weighted score (higher positions count for more) and appearance count, exact URLs by appearance count, and the most common title phrases.
What's on this page
Domain and URL charts, the full result list, and title n-gram tables.
Research: Top, Best Companies
Domains appearing in Google results for Postpartum New Parent's Research: Top, Best Companies queries. Score is a rank-weighted sum (higher-ranked appearances count for more); count is a plain appearance tally.
Top URLs
Individual pages (not just domains) ranked by the same rank-weighted score, labeled by page title.
All Results
Every result for Postpartum New Parent's Research: Top, Best Companies queries, ranked by how many times each exact URL appeared (ties broken by average rank position, so appearing higher up wins), a different aggregation than the score-based charts above. Title and URL links open in a new tab.
Title N-Grams
Most common word phrases (2 to 7 words) across every result title for these queries.
2-grams
| 85 | postpartum depression |
| 9 | for postpartum |
| 6 | new postpartum |
| 6 | depression treatment |
| 5 | fda approves |
| 4 | with postpartum |
| 4 | depression pill |
| 4 | depression drugs |
| 4 | depression and |
| 4 | treatment for |
| 4 | depression market |
| 3 | depression drug |
| 3 | treatment market |
| 3 | of postpartum |
| 3 | treating postpartum |
| 3 | first postpartum |
| 3 | market share |
| 3 | how to |
| 3 | approves new |
| 3 | top postpartum |
| 3 | depression companies |
| 2 | zurzuvae the |
| 2 | the new |
| 2 | depression ppd |
| 2 | causes symptoms |
3-grams
| 9 | for postpartum depression |
| 6 | postpartum depression treatment |
| 5 | new postpartum depression |
| 4 | with postpartum depression |
| 4 | postpartum depression pill |
| 4 | postpartum depression drugs |
| 4 | postpartum depression and |
| 4 | treatment for postpartum |
| 4 | postpartum depression market |
| 3 | postpartum depression drug |
| 3 | depression treatment market |
| 3 | treating postpartum depression |
| 3 | first postpartum depression |
| 3 | fda approves new |
| 3 | top postpartum depression |
| 3 | postpartum depression companies |
| 2 | zurzuvae the new |
| 2 | postpartum depression ppd |
| 2 | treatment market size |
| 2 | of postpartum depression |
| 2 | postpartum depression careers |
| 2 | approved by fda |
| 2 | postpartum depression medication |
| 2 | how to find |
| 2 | helping clients with |
4-grams
| 4 | treatment for postpartum depression |
| 3 | postpartum depression treatment market |
| 3 | first postpartum depression pill |
| 3 | top postpartum depression companies |
| 2 | new postpartum depression drug |
| 2 | depression treatment market size |
| 2 | helping clients with postpartum |
| 2 | clients with postpartum depression |
| 2 | pill for postpartum depression |
| 2 | postpartum depression and workplace |
| 2 | depression and workplace rights |
| 2 | pregnancy postpartum depression dc |
| 2 | postpartum depression dc md |
| 2 | depression dc md va |
| 2 | postpartum depression drugs companies |
| 2 | new treatment for postpartum |
| 2 | sage on zuranolone treatment |
| 2 | on zuranolone treatment for |
| 2 | zuranolone treatment for postpartum |
| 2 | postpartum depression market share |
| 2 | depression market share and |
| 2 | market share and size |
| 2 | share and size report |
| 2 | what is perinatal depression |
| 2 | is perinatal depression formerly |
5-grams
| 2 | postpartum depression treatment market size |
| 2 | helping clients with postpartum depression |
| 2 | postpartum depression and workplace rights |
| 2 | pregnancy postpartum depression dc md |
| 2 | postpartum depression dc md va |
| 2 | new treatment for postpartum depression |
| 2 | sage on zuranolone treatment for |
| 2 | on zuranolone treatment for postpartum |
| 2 | zuranolone treatment for postpartum depression |
| 2 | postpartum depression market share and |
| 2 | depression market share and size |
| 2 | market share and size report |
| 2 | what is perinatal depression formerly |
| 2 | is perinatal depression formerly postpartum |
| 2 | baby blues vs postpartum depression |
| 2 | blues vs postpartum depression south |
| 2 | vs postpartum depression south dakota |
| 2 | postpartum depression screening and follow |
| 2 | depression screening and follow up |
| 2 | screening and follow up pds |
| 2 | and follow up pds e |
| 2 | fda approves new postpartum depression |
| 2 | fda approves first postpartum depression |
| 2 | approves first postpartum depression pill |
| 2 | first postpartum depression pill in |
6-grams
| 2 | pregnancy postpartum depression dc md va |
| 2 | sage on zuranolone treatment for postpartum |
| 2 | on zuranolone treatment for postpartum depression |
| 2 | postpartum depression market share and size |
| 2 | depression market share and size report |
| 2 | what is perinatal depression formerly postpartum |
| 2 | baby blues vs postpartum depression south |
| 2 | blues vs postpartum depression south dakota |
| 2 | postpartum depression screening and follow up |
| 2 | depression screening and follow up pds |
| 2 | screening and follow up pds e |
| 2 | fda approves first postpartum depression pill |
| 2 | approves first postpartum depression pill in |
| 2 | first postpartum depression pill in the |
| 2 | postpartum depression pill in the us |
| 1 | national helpline for mental health drug |
| 1 | helpline for mental health drug alcohol |
| 1 | for mental health drug alcohol issues |
| 1 | zurzuvae the new postpartum depression drug |
| 1 | the new postpartum depression drug now |
| 1 | postpartum depression treatment market size drugs |
| 1 | treatment of postpartum depression clinical psychological |
| 1 | medication options for patients with postpartum |
| 1 | options for patients with postpartum depression |
| 1 | treating postpartum depression 6 medications that |
7-grams
| 2 | sage on zuranolone treatment for postpartum depression |
| 2 | postpartum depression market share and size report |
| 2 | baby blues vs postpartum depression south dakota |
| 2 | postpartum depression screening and follow up pds |
| 2 | depression screening and follow up pds e |
| 2 | fda approves first postpartum depression pill in |
| 2 | approves first postpartum depression pill in the |
| 2 | first postpartum depression pill in the us |
| 1 | national helpline for mental health drug alcohol |
| 1 | helpline for mental health drug alcohol issues |
| 1 | zurzuvae the new postpartum depression drug now |
| 1 | medication options for patients with postpartum depression |
| 1 | treating postpartum depression 6 medications that work |
| 1 | first postpartum depression pill approved by fda |
| 1 | effect of zuranolone vs placebo in postpartum |
| 1 | of zuranolone vs placebo in postpartum depression |
| 1 | new postpartum depression drugs are here diagnosis |
| 1 | today we approved the first oral medication |
| 1 | we approved the first oral medication indicated |
| 1 | approved the first oral medication indicated to |
| 1 | postpartum depression drugs market report 2024 2030 |
| 1 | how to find therapists for postpartum depression |
| 1 | postpartum depression what you need to know |
| 1 | postpartum depression takes life of chicago mother |
| 1 | medication of postpartum depression and maternal outcomes |